Display options
Cite
Ginsburg PM, Bayless TM. Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2005;8(3):211-221doi: 10.1007/s11938-005-0013-0.
Ginsburg, P. M., & Bayless, T. M. (2005). Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Current treatment options in gastroenterology, 8(3), 211-221. https://doi.org/10.1007/s11938-005-0013-0
Ginsburg, Philip M, and Bayless, Theodore M. "Managing Functional Disturbances in Patients with Inflammatory Bowel Disease." Current treatment options in gastroenterology vol. 8,3 (2005): 211-221. doi: https://doi.org/10.1007/s11938-005-0013-0
Ginsburg PM, Bayless TM. Managing Functional Disturbances in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2005 Jun;8(3):211-221. doi: 10.1007/s11938-005-0013-0. PMID: 15913510.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Gastroenterol. 2005 Jun;8(3):211-221. doi: 10.1007/s11938-005-0013-0.

Managing Functional Disturbances in Patients with Inflammatory Bowel Disease.

Current treatment options in gastroenterology

Philip M Ginsburg, Theodore M Bayless

Affiliations

  1. The Johns Hopkins Hospital, 461 Blalock Building, 600 North Wolfe Street, Baltimore, MD 21287, USA. [email protected].

PMID: 15913510 DOI: 10.1007/s11938-005-0013-0

Abstract

Functional disturbances occur in approximately 10% to 15% of the general population and in a similar percentage of patients with inflammatory bowel disease (IBD). Because overlapping irritable bowel syndrome (IBS) is so common, one of the most important interventions a clinician can make is recognizing its existence. This requires a thorough understanding of underlying pathophysiologic processes. Differentiating among the causes of symptoms is especially significant in a minority of patients mislabeled as having 'refractory IBD.' Escalating therapy directed at disease activity may have no effect on functional symptoms other than to reinforce their presence. Treatment of IBS in patients with IBD is similar to that of the general population. The cornerstone of treatment is establishing a constructive doctor-patient relationship. Initial therapy usually involves a conservative approach that includes patient education and diet and lifestyle modifications. Pharmacologic treatment is individualized and generally directed at the predominant symptoms. Options may broadly include antispasmodics, antidiarrheals, and antidepressants, either alone or in combination. Psychosocial therapies have shown to be beneficial in selected individuals.

References

  1. Am J Gastroenterol. 2003 Sep;98 (9):1970-5 - PubMed
  2. Gastroenterology. 1998 Aug;115(2):370-80 - PubMed
  3. Gut. 2003 May;52(5):671-6 - PubMed
  4. Scand J Gastroenterol Suppl. 1992;192:102-5 - PubMed
  5. Lancet. 1996 Jan 20;347(8995):150-3 - PubMed
  6. Gastroenterology. 2002 Dec;123(6):2108-31 - PubMed
  7. Am J Gastroenterol. 1989 Jan;84(1):34-9 - PubMed
  8. Arch Intern Med. 2001 Jul 23;161(14):1733-40 - PubMed
  9. Gastroenterology. 1980 Aug;79(2):283-8 - PubMed
  10. Am J Gastroenterol. 2003 Apr;98(4):750-8 - PubMed
  11. Aliment Pharmacol Ther. 2001 Oct;15(10):1655-66 - PubMed
  12. Aliment Pharmacol Ther. 1997 Dec;11(6):1067-72 - PubMed
  13. Gastroenterology. 1995 Jul;109(1):40-52 - PubMed
  14. Lancet. 2000 Mar 25;355(9209):1035-40 - PubMed
  15. J Surg Res. 1978 Jul;25(1):42-9 - PubMed
  16. Q J Med. 1962 Jul;31:307-22 - PubMed
  17. BMJ. 1999 Feb 27;318(7183):565-6 - PubMed
  18. Aliment Pharmacol Ther. 2004 Feb 1;19(3):245-51 - PubMed
  19. Aliment Pharmacol Ther. 2002 Nov;16(11):1877-88 - PubMed
  20. Gastroenterology. 2002 Aug;123(2):450-60 - PubMed
  21. Gastroenterology. 1976 Nov;71(5):738-42 - PubMed
  22. Am J Gastroenterol. 2002 Apr;97(4):972-7 - PubMed
  23. Gastroenterology. 1982 Sep;83(3):529-34 - PubMed
  24. Aliment Pharmacol Ther. 2001 Mar;15(3):355-61 - PubMed
  25. Gastroenterology. 2002 Jul;123(1):217-26 - PubMed
  26. Am J Med. 2000 Jan;108(1):65-72 - PubMed
  27. Dis Colon Rectum. 1996 Jan;39(1):66-73 - PubMed
  28. Clin Gastroenterol Hepatol. 2003 May;1(3):155-9 - PubMed
  29. Gastroenterology. 1997 Oct;113(4):1224-32 - PubMed
  30. Curr Gastroenterol Rep. 2003 Aug;5(4):331-6 - PubMed
  31. Am J Gastroenterol. 1997 Jan;92(1):103-8 - PubMed
  32. Gastroenterology. 1984 Aug;87(2):314-8 - PubMed
  33. J Am Diet Assoc. 2005 Jan;105(1):110-3 - PubMed
  34. Aliment Pharmacol Ther. 2003 Sep 15;18(6):569-80 - PubMed
  35. Gut. 1983 Mar;24(3):190-2 - PubMed

Publication Types